Health-sector reform in China and access to essential medicines
نویسندگان
چکیده
منابع مشابه
Introduction to Health Sector Reform in China
One of China's great successes during the period of the command economy was to provide a large majority of its population with access to basic health services at an affordable price. This contributed to major improvements in the life of rural people. This issue of the IDS Bulletin asks whether China will be able to maintain cost-effective rural health services as it transforms itself into a mar...
متن کاملHuman resources health supply chains and access to essential medicines
With up to a third of the world’s population with limited access to essential medicines, it is clear that by 2015 many countries will not be able to achieve their health related Millennium Development Goals (MDGs) [1]. Of the eight MDGs, four explicitly discusses the availability of medicines at the primary care or service delivery point level [2]. It is pertinent because without access to and ...
متن کاملEssential medicines pricing--reform needed.
In The Lancet today, Alexandra Cameron and colleagues report on the price, availability, and relative aff ordability of a series of essential medicines in the six WHO administrative regions, in a secondary analysis of data collected in WHO/Health Action International (HAI) surveys. This new report builds on their previous work outlining drug prices in the WHO/HAI database and their relation to ...
متن کاملAccess to essential medicines in national constitutions.
Access to essential medicines is well founded in international law as part of the right to the highest attainable standard of health (" the right to health "). The International Covenant on Economic, Social and Cultural Rights adopted in 1966 calls for States Parties to take steps to ensure access to medical services for all. General Comment 14, added in the year 2000, applies the principles of...
متن کاملThe reform of the essential medicines system in China: a comprehensive approach to universal coverage
In OECD countries, medicines spending accounts for approximately 17% of total health spending or 1.5% of gross domestic product (GDP) [1]. New technologies and pharmaceuticals have been important contributors to rising health care costs. At the same time, patients may not have access to cost–effective medicines because of lack of health insurance coverage, limited insurance benefits, high medic...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet Global Health
سال: 2013
ISSN: 2214-109X
DOI: 10.1016/s2214-109x(13)70077-9